Member Info for Muck165

This one just serves as a useful reminder that Compliance Solutions isn't just involved with getting LFT approvals....

https://www.linkedin.com/posts/edwin-lindsay-5a1980_lifesciences-medicaldevices-ivd-activity-7234439129214652416-hPSy?utm_source=share&utm_medium=member_desktop

Why not - I'll ramp a little....

Massive and growing market

Healthcare becoming decentralised.

Global familiarity with LFT's post C19

Knowledge leaders

Aligned and experienced Directors who have targets, and hit them.

Incentivised management through LTIP

Heavy Institutional backing alongside other long term sticky holders and at v low discount.

Very low free float

Cashflow positive

Growing revenue, controlled costs.

Cash in the bank

Highly diversified customer and product mix

Top tier retail partners

Clear eyes are turned towards the US.

Full service offering. Research, Analytical, Development, Scale Up, Manufacturing, Kitting, Packaging, Regulatory, OEM

Recent acquisitions made largely for paper at par or very low discount.

Huge pipeline potential with National Health Service(s). Two of just 8 companies selected for IDAP are ABDX customers.

Fee for service model means no development risk, and potential manufacturing annuity income across multiple products.

Current automated manufacturing capacity for many millions a year.

Products starting to hit commercialisation phase.

Huge advances in LFT design and accuracy

Abundance of new developers/customers

And then a de-ramp for balance.....

Regulatory approvals are like treacle (hence our beefing up service in that area)

Salistick penetration outside of the UK and Nordics has been painfully slow.

Comms from the company in terms of current projects is poor, albeit explained.

Still a perception that LFT's lack accuracy

No guarantees of product success.

@Gazelleman - your logic seems sound to me. Personally I really struggle to see much downward risk from here, just loads of potential upside.

The most immediate news expectation is the launch of Eco-Flo I think, which the company has all but confirmed will be in September. If they manage it, it will be yet another stated target they’ve hit. After that there’s plenty of other things to watch for with Hormona, Salistick expansion, Upfront UKCA/trial results, Loop sales, Boots expansion, FOFH.

I’m really hoping for some upward movement once the REX is done, and any good news leading to a scramble would be great given the very small free float!

Ultimately, any news of sizeable manufacturing orders is what will make the difference I think. That, or news of major US retail partner for Salistick.

Just a reminder that any applications for the REX offer need to be made with your broker by 16.30 today. Results will be announced tomorrow. Will be interesting to see the take up, and if Directors participated.

REX price isn’t much lower than current Ask, but it is the price that 3 II’s chucked c£5m in at. If they reckon it’s value at that price, no doubt having done DD, then I for one won’t argue with them.

Only 33% here is in public hands.

For info

https://www.linkedin.com/posts/edwin-lindsay-5a1980_lifesciences-medicaldevices-ivd-activity-7234282686066892801-aHvT?utm_source=share&utm_medium=member_desktop

https://info.basilsystems.com/hubfs/CSBasilCaseStudy.pdf

Pure speculation, but Yates/Currivan have periodically reacted to posts from a company called Nordic Dx, most recently this week, and I wouldn’t be surprised to learn we’re involved with them. If we are, then this might be interesting….its a universal LFT digital reader they’ve launched and it could be its using patented AppDx tech, as better described in Mark Jones summit presentation. Of more interest is its potential use with HN51.

https://www.linkedin.com/posts/tommy-selnes-101a9653_nordicdx-innovation-diagnostics-activity-7234139089262813184-NggL?utm_source=share&utm_medium=member_desktop

https://nordicdx.no/wp-content/uploads/2024/08/AIV-Compressed-Report.pdf

HN51 is a problem!

https://www.finddx.org/publications-and-statements/press-release/lack-of-h5n1-influenza-diagnostics-undermines-global-pandemic-readiness/

All speculation of course.

And just for info, but if you look through the admission document you will see Touchstone were early investors in ABDX, funding it on a number of occasions from 2011 onwards.

Whilst it doesn't explain it fully, if you look at section 9 of the TR1 you will see the IP Group own the stock through a number of controlled undertakings, one of which is Touchstone Innovations.

My records show that as at 16 January Touchstone owned 4,164,767 shares, or 3.42% at the time.

Have to admit, I’m at a bit of a loss re today’s TR-1.

IP Group plc say they held nearly 5% of stock prior to the dilution, but I don’t recall ever seeing them on the Significant Shareholder list on the ABDX site.

Whatever, the TR-1 is just reflecting the dilution.

https://www.ipgroupplc.com/

Seems like another sticky holder.

OK - managed to read it.

TBH I didn't see anything particularly new, other than it confirms that EcoTest cassettes will be available from September 2024.

Thanks TF - Is it just me that can’t open it?

On the question of Placings//Director buys, it’s worth having another listen to this from the investor presentation in Jan (between 17.21 and 20.10).

Suggests the Directors will participate I think..

https://www.youtube.com/watch?v=4Z32joS9aD4

I’m hoping the Directors will join in Lucksin. Having them as well as the II’s joining in at such a low discount would send a great message to the mkt.

In truth though, I’d find it a little odd (and disappointing) if they didn’t given the Concert Party changes they made, and the current strength of the company position.

I did say I’m forever the optimist Lucksin!

And to take the fuzzy thoughts a little further, I notice that Yates is a NED at GDR and participated in its REX offer back in May (along with other Directors over there). So we could see Yates and Hand participate in our REX offer.

Well, I’m with HL and haven’t been offered anything close to 9.5p to buy all week. And judging by the trading book, neither has anyone else.

BTW Apre - hope the fingernail’s ok now!

Should have said Tesco online - no idea about the stores.

Have a great long weekend all.

Well, perhaps another reason to sniff optimism here is that Salistick is currently "out of stock" in Tesco.

No idea how much they had, but whatever it was its all gone.

The whole process is new to me Gubbie - never done it before.

But from what I can see the number of brokers listed here https://www.bookbuild.live/deals/N7N5KQ/authorised-intermediaries has grown significantly since I looked earlier in the week. I know most of them are listed as "awaiting confirmation" but I have now idea who is doing the confirming! Is it the broker who needs to confirm they want to participate, or is it the Retail Offer Co-ordinator that needs to give approval to their participation?

I've put my application in.

I can't really see any disadvantage in doing so, and in truth would kick myself if good news dropped shortly after the offer closed and left me scrambling with the mob for stock from the very low free float here.

And you know what, I think Yates truly wants to reward retail holders that have supported the company, and may well be delaying news (for example the Eco-Flo launch or something from the summit presentation) until after the offer closes. ABDX have, for example, told me they will be posting the summit presentation "in August"., and I do ask myself why they've given themselves the flex to do that, after the REX offer closes, rather than just do the more normal thing and post it now.

Forever the optimist me!

For info - a feature on Hormona today in the DE.

https://www.express.co.uk/life-style/health/1938849/I-was-misdiagnosed-with-stress-but-I-have-an-overlooked-condition-here-are-the-signs

A little while ago there was another Hormona piece that said they would be launching their LFT in the Autumn.

Todays DE express piece says "They're gearing up to launch a nifty 15-minute hormone test that you can do from home too. Karolina compared it to a Covid lateral flow test, but for urine samples, which you can then scan with your phone to get instant health analysis." So sounds pretty imminent, and could be using AppDx.